These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 32410564)

  • 1. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Consequences of Autoimmune Rheumatic Diseases.
    Atzeni F; Nucera V; Gerratana E; Fiorenza A; Gianturco L; Corda M; Sarzi-Puttini P
    Curr Vasc Pharmacol; 2020; 18(6):566-579. PubMed ID: 31985379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in autoimmune rheumatic diseases.
    Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
    Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Sjögren's Syndrome and Cardiovascular Disease.
    Melissaropoulos K; Bogdanos D; Dimitroulas T; Sakkas LI; Kitas GD; Daoussis D
    Curr Vasc Pharmacol; 2020; 18(5):447-454. PubMed ID: 31995009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorheumatology: cardiac involvement in systemic rheumatic disease.
    Prasad M; Hermann J; Gabriel SE; Weyand CM; Mulvagh S; Mankad R; Oh JK; Matteson EL; Lerman A
    Nat Rev Cardiol; 2015 Mar; 12(3):168-76. PubMed ID: 25533796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated Atherosclerosis and Management of Cardiovascular Risk in Autoimmune Rheumatic Diseases: An Updated Review.
    Karakasis P; Patoulias D; Stachteas P; Lefkou E; Dimitroulas T; Fragakis N
    Curr Probl Cardiol; 2023 Dec; 48(12):101999. PubMed ID: 37506959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune diseases, their pharmacological treatment and the cardiovascular system.
    Jastrzębska M; Czok ME; Guzik P
    Cardiol J; 2013; 20(6):569-76. PubMed ID: 24338532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine.
    Senécal JL; Chartier S; Rothfield N
    J Rheumatol; 1995 May; 22(5):868-75. PubMed ID: 8587074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspective on rituximab in rheumatic diseases.
    Schioppo T; Ingegnoli F
    Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development.
    Karakontaki FV; Panselinas ES; Polychronopoulos VS; Tzioufas AG
    Autoimmun Rev; 2021 Feb; 20(2):102742. PubMed ID: 33333235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.
    Mavrogeni SI; Sfikakis PP; Dimitroulas T; Koutsogeorgopoulou L; Katsifis G; Markousis-Mavrogenis G; Kolovou G; Kitas GD
    Rheumatol Int; 2018 Jun; 38(6):949-958. PubMed ID: 29516170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular manifestations of rheumatic diseases.
    Goodson NJ; Solomon DH
    Curr Opin Rheumatol; 2006 Mar; 18(2):135-40. PubMed ID: 16462518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Specific Cardiovascular Comorbidities with Associations in Dermatologic and Rheumatic Disorders.
    Kerkhof PLM; Khamaganova I
    Adv Exp Med Biol; 2018; 1065():489-509. PubMed ID: 30051403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
    Jorge AM; Lu N; Keller SF; Rai SK; Zhang Y; Choi HK
    J Rheumatol; 2018 Dec; 45(12):1689-1695. PubMed ID: 30173155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease.
    Escárcega RO; García-Carrasco M; Mendoza-Pinto C
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):311-312. PubMed ID: 32718860
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmunity and autoinflammation: cardiovascular drug targets and design.
    Gasparyan AY
    Curr Pharm Des; 2014; 20(4):483-5. PubMed ID: 23565640
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of dyslipidemia in rheumatic diseases].
    Vordenbäumen S; Schinner S; Halle M; Fischer-Betz R; Schneider M
    Z Rheumatol; 2010 Oct; 69(8):689-92, 694-5. PubMed ID: 20862479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy.
    Bartoloni E; Alunno A; Bistoni O; Gerli R
    Clin Rev Allergy Immunol; 2013 Feb; 44(1):14-22. PubMed ID: 21240669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
    Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
    Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.